¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¾¾ç³»°úÇÐȸ BEST of WCLC 2019 : 2019-11-30

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁ¾¾ç³»°úÇÐȸ BEST of WCLC 2019 : 2019-11-30
±³À°ÀÏÀÚ : 2019-11-30
±³À°Àå¼Ò : ±×·£µå¿öÄ¿Èú ºñ½ºÅ¸È¦ (B2)  
±³À°ÁÖÁ¦ : BEST of WCLC 2019
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-735-2857  
À̸ÞÀÏ : ksmo3@ksmo.or.kr      
±³À°Á¾·ù : ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ 50,000 / ÀüÀÓÀÇ 30,000 / ±âŸ 70,000¿ø´çÀϵî·Ï : Àü¹®ÀÇ 60,000 / ÀüÀÓÀÇ 40,000 / ±âŸ 80,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-30 Room A 08:50~09:30 New Standards of Care in post crizotinib ALK+NSCLC : roles of brigatinib in optimal sequential treatments  È«¹ÎÈñ(¿¬¼¼¾Ïº´¿ø) 
±³À°½Ã°£ 11-30 Room A 09:30~09:50 New Threat of Lung cancer  À̰迵(°Ç±¹´ëÇб³º´¿ø) 
±³À°½Ã°£ 11-30 Room A 09:50~10:10 Update of lung cancer screening at WCLC2019  ±èÅÂÁ¤(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 11-30 Room A 10:10~10:30 Update of Surgery at WCLC2019  TBD(TBD) 
±³À°½Ã°£ 11-30 Room A 10:30~10:50 Evolution of Tissue Testing for Immuno-oncology or Precision oncology  ÀüÀ±°æ(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 11-30 Room A 10:50~11:10 New approach of Immunotherapy for cure of lung cancer  À̼¼ÈÆ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 11-30 Room A 11:10~11:30 Precision trials of lung cancer at WCLC2019  ¹Î¿µÁÖ(¿ï»ê´ëÇб³º´¿ø) 
Åä·Ð 11-30 Room A 11:30~11:40 Q&A  () 
±³À°½Ã°£ 11-30 Room A 11:40~12:30 Optimal treatment strategy to prolong survival in 1st line for EGFR mutant NSCLC patients  ±èŹÎ(¼­¿ï´ëÇб³º´¿ø) 
È޽Ġ11-30 Room A 12:30~13:00 Coffee Break  () 
±³À°½Ã°£ 11-30 Room A 13:00~13:20 Immunotherapy for locoregional disease  ±è¹Ì¼Ò(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 11-30 Room A 13:20~13:40 Optimal management for oligometastitc NSCLC  ÀÓäȫ(°í·Á´ëÇб³¾È»êº´¿ø) 
±³À°½Ã°£ 11-30 Room A 13:40~14:00 Management of N2 disease in the era of IO  ¹Ú¼º¿ë(½ÅÃ̼¼ºê¶õ½ºº´¿ø) 
Åä·Ð 11-30 Room A 14:00~14:20 Discussion  () 
±³À°½Ã°£ 11-30 Room A 14:20~15:00 Targeted Therapy and Chemotherapy  ÃÖÀ±Áö(°í·Á´ëÇб³¾È¾Ïº´¿ø) 
±³À°½Ã°£ 11-30 Room A 15:00~15:30 Immuno-Oncology  À±½Å±³(¼­¿ï¾Æ»êº´¿ø) 
È޽Ġ11-30 Room A 15:30~16:00 Coffee Break  () 
±³À°½Ã°£ 11-30 Room A 16:00~16:30 Small Cell Lung Cancer  È«¼÷Èñ(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 11-30 Room A 16:30~16:55 Thymic Malignacy/Mesothelioma  ÀÓ½ÂÅÃ(¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø) 
Åä·Ð 11-30 Room A 16:55~17:10 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¾¾ç³»°úÇÐȸ BEST of WCLC 2019 : 2019-11-30""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ 2019³â Çмú´ëȸ : 2019-11-30
´ÙÀ½±Û Á¦44Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ½ÉÆ÷Áö¾ö : 2019-11-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20477 ºÎ»ê ´ëÇÑ°£ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ(°£¼¼Æ÷¾ÏÀÇ downstaging: Çö½Ç°ú ¹Ì·¡) : 2024-05-09 0 126 2024-04-29
20476 ÀÎõ Çѱ¹¿©ÀÚÀÇ»çȸ ÀÎõÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö : 2024-05-09 0 91 2024-04-29
20475 Á¦ÁÖ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦ÁÖÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-08 0 96 2024-04-29
20474 Á¦ÁÖ (3ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-04 0 174 2024-04-29
20473 Á¦ÁÖ (2ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-03 0 75 2024-04-29
20472 ÀüºÏ ´ëÇÑÇǺÎÁø±Õ ¹× °¨¿°ÇÐȸ ¼øȸ¿¬¼ö±³À° : 2024-05-03 0 98 2024-04-29
20471 Á¦ÁÖ (1ÀÏÂ÷) 2024³â Á¦24Â÷ Çѱ¹Á¶Á÷°øÇС¤Àç»ýÀÇÇÐȸ Á¤±âÇмú´ëȸ : 2024-05-02 0 102 2024-04-29
20470 ´ë±¸ Á¦ 263Â÷ ´ëÇÑ ÇǺΰúÇÐȸ ´ë±¸°æºÏÁöºÎ Áý´ãȸ(¿øÇü Å»¸ð) : 2024-05-02 0 145 2024-04-29
20469 ±¤ÁÖ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ±¤ÁÖÀü³²Áöȸ Á¦51Â÷ ÇмúÁý´ãȸ : 2024-05-02 0 185 2024-04-29
20468 ºÎ»ê ´ëÇÑÀ忬±¸ÇÐȸ ºÎ¿ï°æÁöȸ Á¤±âÁý´ãȸ : 2024-04-29 0 111 2024-04-29
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 289 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 196 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 160 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 202 2024-04-17
20463 ¼­¿ï 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-26 0 240 2024-04-17
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷